# FDA 483 - Ida Vanessa Doederlein Schwartz, MD - January 31, 2025

Source: https://www.keypedia.com/records/483/ida-vanessa-doederlein-schwartz-md/1a688f97-8b97-4f37-bf6c-24f2f74d8307

> FDA 483 for Ida Vanessa Doederlein Schwartz, MD on January 31, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ida Vanessa Doederlein Schwartz, MD
- Inspection Date: 2025-01-31
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: An FDA inspection of Ida Vanessa Doederlein Schwartz, MD, a clinical investigator in Porto Alegre, Brazil, revealed inadequate record-keeping practices. The inspection found that investigational drug disposition records were not sufficient, specifically regarding the accurate documentation of discrepancies in investigational product accountability. This indicates a significant issue with data integrity and compliance with study protocols.

## Related Officers

- [investigator](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)

Company: https://www.keypedia.com/companies/ida-vanessa-doederlein-schwartz-md/eab42b21-adbc-4655-9ffc-95d6f6e64675

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8